Buried in Wegovy Costs, North Carolina Will Stop Paying for Obesity Drugsnews2024-01-26T18:52:40+00:00January 26th, 2024|The New York Times|
Eli Lilly, Maker of Mounjaro and Zepbound, Wades Into Telehealthnews2024-01-05T21:20:53+00:00January 5th, 2024|The New York Times|
Can Ozempic and Weight Loss Drugs Treat Other Diseases?news2023-12-20T16:09:05+00:00December 20th, 2023|The New York Times|
Drugs like Wegovy Can Fix Teenage Obesity, but Young People Don’t Get Themnews2023-12-11T18:17:26+00:00December 11th, 2023|The New York Times|
Zepbound, el nuevo medicamento aprobado por la FDA para perder pesonews2023-11-13T10:01:53+00:00November 13th, 2023|The New York Times|
Weight Loss Drug Wegovy Can Cut Heart Attack Risk for Some, Study Showsnews2023-11-12T05:20:43+00:00November 12th, 2023|The New York Times|
F.D.A. Approves New Obesity Drug Tirzepatide That Will Compete With Wegovynews2023-11-09T01:02:09+00:00November 9th, 2023|The New York Times|
FDA Approves Zepbound, A Drug Like Ozempic, for Weight Loss. Here’s What to Know.news2023-11-08T18:34:20+00:00November 8th, 2023|The New York Times|
Los medicamentos cotra la obesidad tienen sobreprecio, pero esto puede cambiarnews2023-10-26T09:02:55+00:00October 26th, 2023|The New York Times|
How Much Do Ozempic and Wegovy Cost? Not What You Think.news2023-10-22T07:00:20+00:00October 22nd, 2023|The New York Times|
